5-alpha-reductase deficiency natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 18: Line 18:
{{WS}}
{{WS}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Endocrinology and Metabolic Disease]]
[[Category:Endocrinology]]
[[Category:Genetic disorders]]
[[Category:Genetic disorders]]

Latest revision as of 19:50, 19 September 2012

5-alpha-reductase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 5-alpha-reductase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

Pelvic X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

5-alpha-reductase deficiency natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 5-alpha-reductase deficiency natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 5-alpha-reductase deficiency natural history, complications and prognosis

CDC on 5-alpha-reductase deficiency natural history, complications and prognosis

5-alpha-reductase deficiency natural history, complications and prognosis in the news

Blogs on 5-alpha-reductase deficiency natural history, complications and prognosis

Directions to Hospitals Treating 5-alpha-reductase deficiency

Risk calculators and risk factors for 5-alpha-reductase deficiency natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Complications

With 5-ARD there is a risk of gender identity disorder as well as infertility, due to underdevelopment of seminal vesicles and prostate.

Gender identity disorder

Although most people with 5-ARD identify themselves as females, some, however, may develop a male gender identity coinciding the with the pubertal virilisation, or can present themselves with apparent gender dysphoria and transgender behavior. Most cases of gender (role) changes have been reported in large families in the Dominican Republic and Sao Pablo. It is unclear if these patients had the means or possibilities to be treated against virilisation. In some cultures it seems to be socially more beneficial to be a man, than an infertile woman. It is unclear whether this has played any part in the above mentioned gender changes.

Infertility

There is an increased risk of cryptorchidism in 5-ARD, causing infertility, but also a higher risk of testicular cancer. Fertility is further compromised by the underdevelopment of seminal vesicles and prostate.

On the other hand, fertility depending on the female characteristics are impossible; Although the external genitalia appear female, the "pseudovagina" consists only of the lower two-thirds of a normal vagina; creating a blind-ending vaginal pouch. Due to the normal action of Müllerian inhibiting factor produced by the testis in utero, individuals with 5-ARD lack a uterus and Fallopian tubes. Thus, individuals with 5-ARD are not able to become pregnant or produce ova.

References

Template:WH Template:WS